The issue of compounded, injectable drugs has been a national issue over the last two years. Recent clusters of serious infections from compounding pharmacies in several states have raised national concerns about oversight and regulation of compounded medications.


It is critical that there is a reliable supply of Avastin for intravitreal injection, which is a highly cost effective, sight-saving drug for a variety of retinal diseases. The FDA and state pharmacy boards have developed Federal and State legislation to address some of these concerns. Ultimately, it is imperative that physicians have oversight and input regarding the quality and safety of their Avastin supply and work directly with their compounding pharmacy to ensure the highest possible standards.


Contact Us


NorthMark Back To Top